LAUREN CURALOV: Open Payments
NPI 1194585307 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,981 in 102 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $425 · 2025 $1,981
Food & beverage: $1,897Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $810 |
| Phathom Pharmaceuticals, Inc. | 12 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $186 |
| Janssen Biotech, Inc. | 12 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| Intercept Pharmaceuticals, Inc. | 3 | $74 |
| Madrigal Pharmaceuticals | 2 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| GENZYME CORPORATION | 3 | $61 |
| Ipsen Biopharmaceuticals, Inc | 1 | $35 |
Products named: RINVOQ, VOQUEZNA, SKYRIZI, TREMFYA, ENTYVIO, DUPIXENT, XIFAXAN, OCALIVA.
Industry payments across MA — which companies pay providers there.
